Treatment Access at a Glance
At the center of our model is a patient who has been diagnosed with a certain cancer and prescribed a treatment for which no local access exists by one of our partner physicians. Working in collaboration with a robust network of leading cancer treating institutions and physicians, drug manufacturers, an international distributor, and local patient support organizations, we provide humanitarian access to the treatment with the aim that each required daily dose reaches the intended patient at the right time, while strengthening the local healthcare system.
The Max Foundation has extensive experience in managing patient access programs for oncology products. The MAS model guidelines are the result of the best practices and expertise developed through this extensive experience. These guidelines are reviewed and updated periodically and shared externally with Donor Companies, Health Authorities, and other relevant stakeholders. They are meant to provide a foundation for the development of internal procedures for product requests under MAS. The guidelines further aim to align with World Health Organization (WHO) international guidelines for product donation as well as Partnership for Quality Medical Donations’ (PQMD) standards for international product donations.